Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · January 12, 2022

Assessment and Management of ROP in the Era of Anti–VEGF

Progress in Retinal and Eye Research


Additional Info

Progress in Retinal and Eye Research
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)
Prog Retin Eye Res 2021 Nov 09;[EPub Ahead of Print], AS Tsai, HD Chou, XC Ling, T Al-Khaled, N Valikodath, E Cole, VL Yap, MF Chiang, RVP Chan, WC Wu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading